Transcriptomic characterization of hepatocellular carcinoma with CTNNB1 mutation. - Wikidata - awgldk - TriplyDB

Transcriptomic characterization of hepatocellular carcinoma with CTNNB1 mutation.

Transcriptomic characterization of hepatocellular carcinoma with CTNNB1 mutation.

http://www.wikidata.org/entity/Q33567714

about

Genetic alterations in hepatocellular carcinoma: An update Aberrant regulation of Wnt signaling in hepatocellular carcinoma MYC Deregulation in Primary Human Cancers.Dual roles of NRF2 in tumor prevention and progression: possible implications in cancer treatment Cytoplasmic and/or nuclear expression of β-catenin correlate with poor prognosis and unfavorable clinicopathological factors in hepatocellular carcinoma: a meta-analysis.Prevalence of National Responsiveness to HBV Vaccine After 22 Years of Iranian Expanded Program on Immunization (EPI): A Systematic Review and Meta-Analysis Study Action and function of Wnt/β-catenin signaling in the progression from chronic hepatitis C to hepatocellular carcinoma.Theranostical nanosystem-mediated identification of an oncogene and highly effective therapy in hepatocellular carcinoma.Gene signature driving invasive mucinous adenocarcinoma of the lung.Bidirectional reporter assay using HAL promoter and TOPFLASH improves specificity in high-throughput screening of Wnt inhibitors.Combined effects of PLK1 and RAS in hepatocellular carcinoma reveal rigosertib as promising novel therapeutic "dual-hit" option.

P2860

Q28073241-4D0A5D5E-4621-4E40-A530-844FCC9A1712 Q28079789-75B6D2AE-0FAA-4F6E-A196-BB73804E2182 Q33836755-21A1C355-A6A5-4B3A-B7B3-D11EA7ADF775 Q35118710-F0BD46E9-53FB-4F6E-94AB-CEF493F45C8B Q35424206-B7513089-BE4E-421D-86E0-86959668ECCD Q35671639-3CAB0E31-C044-45AE-A641-856973A27576 Q39062813-070160CE-CFA3-4BB5-BAB7-C284F6124D6C Q41039458-82F9BD51-ABD4-44AA-A882-C58077EE1FBD Q42293061-D98E6171-AB10-41B5-8B11-6BD31108F5AA Q48013783-EB09B1A9-580C-4C70-B1E5-70DBC0D2DD3B Q49402953-2B2C2AFE-2A9A-409C-B815-DB142CB78BE9

P2860

Transcriptomic characterization of hepatocellular carcinoma with CTNNB1 mutation.

http://www.wikidata.org/entity/Q33567714

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Transcriptomic characterization of hepatocellular carcinoma with CTNNB1 mutation.

@ast

Transcriptomic characterization of hepatocellular carcinoma with CTNNB1 mutation.

@en

Transcriptomic characterization of hepatocellular carcinoma with CTNNB1 mutation.

@nl

type

label

Transcriptomic characterization of hepatocellular carcinoma with CTNNB1 mutation.

@ast

Transcriptomic characterization of hepatocellular carcinoma with CTNNB1 mutation.

@en

Transcriptomic characterization of hepatocellular carcinoma with CTNNB1 mutation.

@nl

prefLabel

Transcriptomic characterization of hepatocellular carcinoma with CTNNB1 mutation.

@ast

Transcriptomic characterization of hepatocellular carcinoma with CTNNB1 mutation.

@en

Transcriptomic characterization of hepatocellular carcinoma with CTNNB1 mutation.

@nl

P1433

Q33567714-D60AFE1D-89B2-437F-8C00-26EB111C2624

P1476

Q33567714-EADA02D9-7CD3-4060-981F-0BA1EBCB3FB5

P2093

Q33567714-47E88450-3C59-4E0B-947C-705BB27A6D3B

Q33567714-6189B7DE-FEFC-4688-A440-AF14FDB4C2F0

Q33567714-80A503FA-AC2A-48A5-AB55-4CB9FFD3DD88

Q33567714-95B71F95-6B3B-44CD-9C20-7E37DCC0B547

Q33567714-A8F45555-C55E-4516-8E17-039F08565900

Q33567714-B0DEBEAC-AC14-4067-AD0C-A0A6A7D73CBD

Q33567714-DEA36036-9AAF-482A-96D9-FD69DCC81063

Q33567714-FC0C2784-76DD-4ED9-8B02-984DA665DFB1

Q33567714-FE47FDBA-01DE-44A7-9CC6-2358AD5EE345

Q33567714-FE78E258-87ED-42E0-92B9-D3C410C83787

P2860

Q33567714-0F31CB73-B082-4071-8AE1-69BDECA32D3C

Q33567714-16B49BF0-8E98-4C94-ADD7-9C454667265A

Q33567714-1FE2B9B1-0004-46A0-9AE2-B6944118BB3D

Q33567714-3E9BCD05-8ACF-478B-8504-CCFCA858EC54

Q33567714-40F55753-D903-40B6-B850-C03285EF55EE

Q33567714-4612899C-642C-4343-8DC5-FC5DEB9329A7

Q33567714-6B36BC2C-6890-4C15-8A53-1CA16C1DC217

Q33567714-6BE44BB6-9B63-4B00-ACDA-0E1B7E4D7D38

Q33567714-6E03D355-A83B-4413-9DF3-2D362EC8ACEA

Q33567714-788BFA4A-728B-40C1-8652-B1DCE41AD3A8

P304

Q33567714-EC32E892-A022-4DEB-918F-C657006F8161

P31

Q33567714-25F66725-EA3E-439F-8609-481D9CC11C75

P356

Q33567714-27D0CC82-45FC-4426-8F8B-D363359AB4F8

P407

Q33567714-67EB55F4-6DC7-4830-B5BC-E16994FE108B

P433

Q33567714-B1ED30FC-C485-4056-8FB8-07493FB395BC

P478

Q33567714-B2BB64B0-CFF2-4DDE-80C0-8BFEC0D00D99

P50

Q33567714-510F4072-AACF-4CBA-9E5B-F23FD131267F

P577

Q33567714-AC370975-9CEC-4F52-B0EF-0D2AC1109D62

P5875

Q33567714-6FD36DB0-7A63-4C78-8E23-764743F42575

P698

Q33567714-457C581E-CE62-4AC3-B5F6-D64E234BF36F

P921

Q33567714-80765CEA-F4F8-42EA-9A2B-D3DCD6ADA775

P932

Q33567714-365EB037-D560-4568-AF07-CC6525F34ABA

P356

JOURNAL.PONE.0095307

P1433

P1476

Transcriptomic characterization of hepatocellular carcinoma with CTNNB1 mutation.

@en

P2093

Aiqun Zhang

http://www.w3.org/2001/XMLSchema#string

Baoda Han

http://www.w3.org/2001/XMLSchema#string

Chengzhi Du

http://www.w3.org/2001/XMLSchema#string

Huanwei Huang

http://www.w3.org/2001/XMLSchema#string

Liang Chen

http://www.w3.org/2001/XMLSchema#string

Naiqing Xu

http://www.w3.org/2001/XMLSchema#string

Tao Cai

http://www.w3.org/2001/XMLSchema#string

Weiping Zhou

http://www.w3.org/2001/XMLSchema#string

Xiao Ding

http://www.w3.org/2001/XMLSchema#string

Yuan Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Two genetic hits (more or less) to cancer

Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis

Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas

Beta-catenin is temporally regulated during normal liver development

Hepatocellular carcinoma pathogenesis: from genes to environment

Primary liver cancer: worldwide incidence and trends

beta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance.

Risk factors for primary liver carcinoma in Chinese population

P304

e95307

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0095307

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-05-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262071600

http://www.w3.org/2001/XMLSchema#string

P698

24798046

http://www.w3.org/2001/XMLSchema#string

P921

P932

4010419

http://www.w3.org/2001/XMLSchema#string